Treatment for B-cell-type lymphoma in a girl associated with Bloom's syndrome.
A 12-year-old girl suffering from Bloom's syndrome developed B-cell-type lymphoma in the epipharynx. She was identified as having Bloom's syndrome at the age of 3. While the tumor was eradicated completely by induction chemotherapy, the bone marrow suppression was severe and persistent. For this reason, we modified subsequent chemotherapy to a milder form. Thus the remaining therapy could be safely completed. This is the first case clearly diagnosed as having epipharyngeal B-cell-type lymphoma in the Bloom's Syndrome Registry.
Oto
S
S
Division of Hematology, Chiba Children's Hospital, Japan.
Miyamoto
S
S
Kudoh
F
F
Horie
H
H
Kinugawa
N
N
Okimoto
Y
Y
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001816:Bloom Syndrome / Q000150:complications*; D002648:Child; D002869:Chromosome Aberrations; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage; D016393:Lymphoma, B-Cell / Q000150:complications* / Q000235:genetics; D008727:Methotrexate / Q000008:administration & dosage; D010610:Pharyngeal Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000235:genetics; D011239:Prednisolone / Q000008:administration & dosage; D011379:Prognosis; D012074:Remission Induction
D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone; D006854:Hydrocortisone; D008727:Methotrexate